drug
conestat alfa
Marketedupdated 3mo agoby Pharming Healthcare, Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying conestat alfa
- phase2Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation
- phase2Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection
- phase2Prevention of Acute Kidney Injury in Patients With NSTEMI
- phase2Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that